Cohance Lifesciences Limited
COHANCE
Rang in Aktien
#6384
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aktienkurs
$5.05
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$1.93B
Veränderung (1 Tag)
-1.44%
Veränderung (1 Jahr)
-57.38%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategorie
Healthcare
Dividendenrendite-Verlauf für Cohance Lifesciences Limited (COHANCE)
Dividendenrendite (TTM) von Cohance Lifesciences Limited (Aktienkürzel: COHANCE) zum 2024-03-31: 0.00%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.51%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.51%
Dividendenrendite-Verlauf für Cohance Lifesciences Limited (COHANCE) von 2019 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
| Jahr | Dividendenrendite | ändert |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | 1.69% | 160.00% |
| 2022 | 0.65% | 225.00% |
| 2021 | 0.20% | -93.33% |
| 2020 | 3.00% | 455.56% |
| 2019 | 0.54% | 0.00% |
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | Dividendenrendite | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
